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Introduction
Congenital diarrheal disorders (CDD) are a group of
rare chronic enteropathies caused by heterogeneous
genetic defects and are characterized by severe diarrhea
in infancy. Berni Canani et al [1] suggested that CDD be
classified into four categories in relation to the defects:
(1) defects of digestion, absorption and transport of
nutrients and electrolytes: congenital lactase deficiency
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SUMMARY
Objective: To present prenatal ultrasound findings and molecular diagnosis of microvillus inclusion disease,
and to review the literature of abnormal prenatal ultrasound findings associated with congenital diarrhea.
Materials, Methods and Results: A 21-year-old woman, gravida 1, para 0, had generalized bowel dilation of the
fetus on prenatal ultrasound at 29 gestational weeks. She and her husband were non-consanguineous, and there
was no family history of congenital diarrhea. Prenatal ultrasound at 29 gestational weeks revealed a honeycomb
appearance of the bowel without ascites or intraperitoneal calcification. At 36 gestational weeks, polyhydramnios
dilated bowel loops were observed, and a 3,355-g male baby was delivered with a distended abdomen. Post-
natally, the neonate suffered from watery diarrhea and abdominal distension but there was no mechanical bowel
obstruction. An endoscopic biopsy of the small bowel revealed intracytoplasmic inclusions lined by intact microvilli
in the apical surface of the intestinal epithelial cells consistent with the diagnosis of microvillus inclusion disease.
Mutation analysis of blood samples of the neonate and parents revealed a heterozygous nonsense mutation of
c.445C>T, p.Q149X in exon 4 of the MYO5B gene in the father and proband, and a heterozygous nonsense
mutation of c.1021C>T, p.Q341X in exon 9 of the MYO5B gene in the mother and proband.
Conclusion: Prenatal sonographic identification of dilated bowel loops in association with polyhydramnios
suggests congenital diarrhea and a differential diagnosis of microvillus inclusion disease in addition to congeni-
tal chloride diarrhea and congenital sodium diarrhea. Molecular analysis of the MYO5B gene is helpful in
genetic counseling and prenatal diagnosis of recurrent microvillus inclusion disease in subsequent pregnancies.
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(LCT gene), sucrase-isomaltase deficiency (SI gene),
maltase-glucoamylase deficiency (MGAM gene), glucose-
galactose malabsorption (SLC5A1 gene), fructose mal-
absorption (GLUT5 gene), Fanconi-Bickel syndrome
(GLUT2 gene), cystic fibrosis (CFTR gene), acrodermati-
tis enteropathica (SLC39A4 gene), congenital chloride
diarrhea (SLC26A3 gene), congenital sodium diarrhea
(SPINT2 gene), lysinuric protein intolerance (SLC7A7
gene), congenital bile acid diarrhea (SLC10A2 gene),
enterokinase deficiency (PRSS7 gene), trypsinogen defi-
ciency (PRSS1 gene), pancreatic lipase deficiency (PNLIP
gene), abetalipoproteinemia (MTP gene), hypobetalipo-
proteinemia (APOB gene) and chylomicron retention
disease (SAR1B gene); (2) defects of enterocyte differ-
entiation and polarization: microvillus inclusion disease
(MVID) (MYO5B gene), congenital tufting enteropathy
(EpCAM gene) and syndromic diarrhea; (3) defects of
enteroendocrine cell differentiation: enteric anendo-
crinosis or congenital malabsorptive diarrhea (NEUROG3
gene), enteric dysendocrinosis and proprotein convertase
1 deficiency (PCSK1 gene); and (4) defects of modula-
tion of the intestinal immune response: immunodysreg-
ulation polyendocrinopathy, enteropathy and X-linked
syndrome (IPEX) (FOXP3 gene), IPEX-like syndrome,
immunodeficiency-associated autoimmune enteropathy,
autoimmune polyendocrine syndrome-1 (AIRE gene)
and autoimmune enteropathy with colitis-generalized
autoimmune gut disorder. Most defects of CDD are
inherited as an autosomal recessive trait, and IPEX is
inherited as an X-linked recessive trait. We present here
the prenatal ultrasound findings and molecular genetic
diagnosis of MVID, a very rare autosomal recessive dis-
order, which belongs to CDD category II.
Materials, Methods and Results
A 21-year-old woman, gravida 1, para 0, had general-
ized bowel dilation of the fetus on prenatal ultrasound
at 29 gestational weeks. Her husband was 37 years old.
She and her husband were non-consanguineous, and
there was no family history of congenital malformations
or CDD. During this pregnancy, a maternal serum screen-
ing test for Down syndrome was negative. Routine sono-
graphic examinations were normal until 29 gestational
weeks when prenatal ultrasound showed a honeycomb
appearance of the bowel with generalized dilation of the
bowel from the small intestines to colon with a thick
intestinal wall but without ascites or intraperitoneal
calcification (Figure 1). The amniotic fluid index was
normal. Other organs were unremarkable. Maternal
TORCH (toxoplasmosis, rubella, cytomegalovirus and
herpes simplex) serologic test results were negative. 
A tentative diagnosis of congenital megacolon or imper-
forate anus was made. At 36 gestational weeks, poly-
hydramnios (amniotic fluid index=27.3 cm) was evident
in addition to the dilated bowel loops (Figure 2), and
a 3,355-g male baby was delivered with a distended
abdomen and respiratory distress. Postnatally, the neo-
nate suffered from watery diarrhea and abdominal dis-
tension but there was no mechanical bowel obstruction.
An endoscopic biopsy of the small bowel revealed 
intracytoplasmic inclusions lined by intact microvilli in
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Figure 1. Prenatal ultrasound at 29 gestational weeks showing (A) a honeycomb appearance of multiple dilated loops of




Figure 2. Prenatal ultrasound showing fluid-filled bowel
loops at 36 gestational weeks.
the apical surface of the intestinal epithelial cells con-
sistent with the diagnosis of MVID. The neonate was
on long-term total parenteral nutrition but died of sep-
sis, malnutrition and multiple organ failure at the age of
6 months. Mutation analysis of peripheral blood sam-
ples of the neonate and the parents revealed a
c.445C>T nonsense mutation in exon 4 of the MYO5B
gene that predicts a p.Q149X in the neonate and the
father (Figure 3), and a c.1021C>T nonsense muta-
tion in exon 9 of the MYO5B gene that predicts a
p.Q341X in the neonate and the mother (Figure 4).
Discussion
MVID or DIAR2, diarrhea 2 with microvillus atrophy
(OMIM 251850), is an autosomal recessive disorder of
intestinal epithelial cells. MVID is characterized by in-
tractable life-threatening watery diarrhea during infancy
and can be caused by mutations in the MYO5B gene
(OMIM 606540) on chromosome 18q21. MVID was
first described by Davidson et al [2] in 1978 as familial
enteropathy presenting with protracted diarrhea from
birth, failure to thrive and hypoplastic villus atrophy.
Characteristic pathologic and electron-microscopic find-
ings of MVID include atrophy of microvilli on mature
enterocytes, apical accumulation of numerous periodic-
acid-Schiff-positive secretory granules in immature en-
terocytes, and microvillus inclusion bodies containing
rudimentary or fully differentiated microvilli in mature
enterocytes [3–5].
Other DIAR categories in OMIM include DIAR1:
congenital chloride diarrhea (OMIM 214700) caused by
mutations in the SLC26A3 gene (OMIM 126650) on
chromosome 7q31; DIAR3: congenital sodium diarrhea
(OMIM 270420) caused by mutations in the SPINT2
gene (OMIM 605124) on chromosome 19q13.1; DIAR4:
congenital malabsorptive diarrhea (OMIM 610370)
caused by mutations in the NEUROG3 gene (OMIM
604882) on chromosome 10q21.3; and DIAR5: con-
genital tufting enteropathy (OMIM 613217) caused
by mutations in the EpCAM gene (OMIM 185535) on
chromosome 2p21. All are rare autosomal recessive
disorders.
The present case was associated with early-onset
MVID and novel heterozygous nonsense mutations in
the MYO5B gene (c.445C>T, p.Q149X and c.1021C>T,
p.Q341X). Both nonsense mutations predict early trun-
cation of MYO5B and cause loss of MYO5B function.
Müller et al [6] first identified seven different nonsense,
missense, splice-site or in-frame insertion mutations 
in the MYO5B gene in patients with MVID from seven
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Figure 3. A heterozygous nonsense mutation (c.445C>T, p.Q149X) in exon 4 of the MYO5B gene in the father and proband.
families. MYO5B encodes the unconventional class V
dimeric non-filamentous myosin, or myosin Vb, which
regulates membrane trafficking along the recycling
pathway in polarized epithelial cells [6,7]. Mutations
of the MYO5B gene disrupt epithelial cell polarity, and
loss-of-function mutations of MYO5B are a major cause
of MVID [6,8,9]. There are two types of MVID: the early-
onset type presenting watery diarrhea within the first
day of life and the late-onset type presenting symptoms
after 3 or 4 months of life [6]. In patients with MVID
without transplantation, the prognosis is very poor be-
cause there is no successful medical treatment, and the
patients remain dependant on total parenteral nutrition
and are likely complicated with metabolic decomposi-
tion, sepsis and/or liver failure. Recently, small bowel
transplantation with or without liver transplantation
and colon grafting for the treatment of MVID have
achieved variable success [10–14].
The present case manifested multiple dilated loops
of small and large bowel at 29 gestational weeks and
polyhydramnios at 36 gestational weeks. The present
case provides evidence that fetuses with MVID may pres-
ent multiple dilated loops of bowel and polyhydramnios
mimicking intestinal obstruction in the early third tri-
mester. To date, there has only been one report of MVID
prenatally presenting as multiple dilated loops of bowel
and polyhydramnios [15]. To our knowledge, the pres-
ent case is the second case report of this condition.
Phillips and Schmitz [3] surveyed 23 cases of MVID but
did not describe abnormal prenatal findings of bowel
dilation and polyhydramnios in their series. Ruemmele
et al [4] suggested that in cases of MVID, the preg-
nancy and delivery are generally uneventful, and there
is no polyhydramnios except in rare isolated cases. Our
case is one of those rare isolated cases. We consider
that the unusual severe prenatal phenotype in this case
may be in part due to a genotype-phenotype correlation
of concomitant nonsense mutations of the MYO5B gene
in association with early truncation of MYO5B, and pre-
natal severe bowel dilation and polyhydramnios. We
suggest that prenatal diagnosis of dilated bowels should
include a differential diagnosis of MVID in addition to
jejunoileal atresia, volvus, meconium ileus, meconium
peritonitis, Hirschsprung’s disease, cystic fibrosis, enteric
duplications, anorectal atresia, congenital sodium diar-
rhea, and congenital chloride diarrhea.
Enterocyte differentiation and polarization defects
and iron transport defects associated with CDD have
been reported to present dilated bowel and poly-
hydramnios on prenatal ultrasound (Table). Kirkinen
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Figure 4. A heterozygous nonsense mutation (c.1021C>T, p.Q341X) in exon 9 of the MYO5B gene in the mother and
proband.
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and Jouppila [16] first reported distended loops of fetal
intestine and polyhydramnios at 26–35 gestational
weeks in three fetuses affected with congenital chlo-
ride diarrhea. Langer et al [17] reported a false diag-
nosis of intestinal obstruction in a fetus with congenital
chloride diarrhea. The fetus manifested multiple
dilated fluid-filled loops of intestine and polyhydram-
nios on prenatal ultrasound similar to that seen with
intestinal obstruction. Kennea et al [15] reported con-
genital MVID presenting as prenatal bowel obstruction
in a 35-gestational-week fetus with polyhydramnios and
multiple dilated loops of small and large bowel. They
suggested that ultrasound may prenatally identify some
cases with MVID, and careful postnatal assessment of
congenital enteropathy is needed in such cases if there
is no evidence of bowel obstruction. Colombani et al
[18] reported prenatal diagnosis of multiple dilated
bowel loops, polyhydramnios and elevated amniotic
fluid electrolyte concentrations in two cases with con-
genital chloride diarrhea and in two cases with con-
genital sodium diarrhea at 22–30 gestational weeks.
Since MVID is an autosomal recessive disorder, the
recurrence risk is 25% for the family that has had a pre-
vious affected child with MVID. Currently, prenatal diag-
nosis can be made by molecular genetic diagnosis in
early pregnancy or by preimplantation genetic diagno-
sis in addition to prenatal ultrasound diagnosis of a
dilated bowel and polyhydramnios in pregnancies with
a positive family history. We suggest that MVID be con-
sidered a possible diagnosis in cases in which prenatal
ultrasound findings manifest a distended bowel in
combination with polyhydramnios.
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